Skip to main content
Funded Studies

Mechanisms Overwhelming Protein and Organelle Quality Control in Parkinson’s Disease

Study Rationale:
Abnormal protein aggregation and prion-like aggregate spreading are hallmarks of the degenerative cascades of sporadic and familial Parkinson’s disease (PD) and can damage cells, including neurons. Multiple mechanisms of aggregate toxicity have been implicated in cellular PD pathology, and PD risk alleles may have the potential to illuminate additional underlying biological mechanisms.

Parkinson’s disease, at the molecular level, results from the failure of cellular quality control (QC) mechanisms, and finding ways to maintain (or augment) QC capacity will provide new therapeutic strategies for PD and possibly other neurodegenerative disorders.

Study Design:
Using powerful molecular visualization and discovery tools in disease-relevant cells, we will elucidate how individual types of protein aggregates linked with PD strains (including patient-derived aggregates) alter cellular pathways, including effects on cell survival and function. We will also use genetic approaches to understand what cellular proteins promote processing of PD-related aggregates.

Impact on Diagnosis/Treatment of Parkinson’s Disease:
Our expectation is that this work will identify those critical cellular functions that are disrupted by protein aggregates and will help define how mutations alter the underlying mechanisms of dysfunctional proteostasis.

Next Steps for Development:
If specific steps in protein quality control affected in PD can be identified, the next phase of experiments will involve a search for molecules that can bypass or repair such defects.


  • J. Wade Harper, PhD

    Boston, MA United States

  • Ruben Fernandez-Busnadiego, PhD

    Göttingen Germany

  • Judith Frydman, PhD

    Stanford, CA United States

  • Franz-Ulrich Hartl, MD

    Martinsried Germany

  • Brenda A. Schulman, PhD

    Martinsried Germany

Discover More Grants

Search by Related Keywords

Within the Same Program

Within the Same Funding Year

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.